-

Jasper Therapeutics, Inc. (JSPR) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR) investors concerning the Company’s possible violations of federal securities laws.

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN JASPER THERAPEUTICS, INC. (JSPR), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.

Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@howardsmithlaw.com, by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.

What Happened?

On July 7, 2025, Jasper released an update on its Phase 1b/2a clinical study of subcutaneous briquilimab for the treatment of Chronic Spontaneous Urticaria (“CSU”), referred to as the “BEACON Study,” stating that certain results “appear to be confounded by an issue with one drug product lot used in those cohorts, with 10 of the 13 patients dosed with drug from the lot in question,” and that Jasper was “taking steps to ensure that drug product from the lot in question is returned to the Company and that sites have drug product from other lots to continue dosing.” Further, the Company revealed it “has also determined that the drug product lot in question was used to treat participants enrolled in the ETESIAN [Study]. As a result, and in order to focus resources on advancing briquilimab in CSU, the Company is halting the study and pausing development in asthma.” Jasper also disclosed that it would be “halting development in SCID” and “will be implementing a number of other cost cutting measures including a potential restructuring, to extend runway and reduce expenses.”

On this news, Jasper’s stock price fell $3.73, or 55.1%, to close at $3.04 per share on July 7, 2025, thereby injuring investors.

Contact Us To Participate or Learn More:

If you purchased Jasper securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
Law Offices of Howard G. Smith,
3070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020,
Telephone: (215) 638-4847
Email: howardsmith@howardsmithlaw.com,
Visit our website at: www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Contact Us:
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

Law Offices of Howard G. Smith

NASDAQ:JSPR

Release Versions

Contacts

Contact Us:
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

More News From Law Offices of Howard G. Smith

Deadline Alert: Portillo's Inc. Stockholders Face January 11, 2027 Lead Plaintiff Deadline in Securities Fraud Class Action, The Law Offices of Howard G. Smith Highlights

BENSALEM, Pa.--(BUSINESS WIRE)--Portillo's Inc. ("Portillo's" or the "Company") (NASDAQ: PTLO) investors who wish to serve as lead plaintiff in a pending securities fraud class action lawsuit must move the Court by January 11, 2027. The suit was filed on behalf of investors who purchased or otherwise acquired the Company's securities from September 19, 2023 through May 4, 2026, inclusive. The Law Offices of Howard G. Smith today highlighted the deadline in the case, Wassel v. Portillo's Inc. et...

Deadline Alert: Nuscale Power Corporation Stockholders Face January 11, 2027 Lead Plaintiff Deadline in Securities Fraud Class Action, The Law Offices of Howard G. Smith Highlights

BENSALEM, Pa.--(BUSINESS WIRE)--Nuscale Power Corporation ("Nuscale" or the "Company") (NYSE: SMR) investors who wish to serve as lead plaintiff in a pending securities fraud class action lawsuit must move the Court by January 11, 2027. The suit was filed on behalf of investors who purchased or otherwise acquired the Company's securities from February 27, 2026 through September 10, 2026, inclusive. The Law Offices of Howard G. Smith today highlighted the deadline in the case, Chiu-Yueh Chang v....

Securities Fraud Class Action Lawsuit Pending Against Fervo Energy Company: The Law Offices of Howard G. Smith Highlights Lead Plaintiff Deadline

BENSALEM, Pa.--(BUSINESS WIRE)--Fervo Energy Company ("Fervo" or the "Company") (NASDAQ: FRVO) is the subject of a securities fraud class action lawsuit filed on behalf of investors who purchased or otherwise acquired Class A common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s May 13, 2026 initial public offering (“IPO” or the “Offering”). Plaintiff pursues claims under Section 1...
Back to Newsroom